skip to Main Content

Stanson enables provider compliance with the PAMA imaging clinical decision support mandate

Based on the proposed rules recently released by the Centers for Medicare and Medicaid Services (CMS), Stanson is confident that our CDS platform will be qualified as a mechanism for use in meeting the requirements of the Protecting Access to Medicare Act (PAMA).

Stanson has three years of data demonstrating the ability of our CDS to significantly decrease inappropriate ordering without frequently disrupting providers. Our intelligent scenario identification logic and efficient user interface will help providers avoid clicking boxes and re-entering data just to confirm an order’s appropriateness while still enabling consideration of appropriate alternatives for a particular clinical scenario. We are also collaborating with major EHR vendors to offer seamless CDS for ordering professionals and to ensure that evidence of CDS consultation is readily available for furnishing professionals. Ultimately, this will minimize the time required to meet CDS consultation requirements for applicable imaging orders.

Stanson is working closely with several qualified provider led entities (qPLEs) to give providers the flexibility to choose the best appropriate use criteria (AUC) for each of the eight priority clinical areas. We are also actively pursuing relationships with all qPLEs to offer access to robust AUC libraries that can support providers’ own clinical initiatives. Regardless of AUC source, all Stanson CDS is designed to be delivered in a manner that is consistent and complementary with other CDS, including the lab and medication recommendations found in our highly effective Choosing Wisely content.

Additionally, Stanson Analytics uniquely provides not only the capability to report on PAMA-related CDS, but also delivers reporting on the additional CDS to which providers are exposed, such as third party medication and in-house custom alerts. Advanced alerting pattern analysis and alert summarization features enable organizations to optimize their deployed content so as to obtain the maximum benefit from their CDS investments.

Although CDS mechanisms will not be officially qualified until June of 2017, Stanson plans to begin rolling out our PAMA-compliant CDS offering to customers in early-to-mid 2017. With this release timeline and our strong track record of fast and successful implementations, we are confident that we will be able to ensure that all of our customers will achieve PAMA compliance ahead of the 1/1/2018 deadline.

Back To Top
Stanson Health